Clinical trial
Tranexamic Acid in Revision Total Joint Arthroplasty: A Prospective Randomized Controlled Trial
NCT02877381 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tranexamic Acid in Revision Total Joint Arthroplasty: A Prospective Randomized Controlled Trial
- Lead sponsor
- Rush University Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- April 30, 2016
- Completion date
- August 1, 2019
- Enrollment
- 175 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
acute blood loss anemia, revision total hip arthroplasty, revision total knee arthroplasty